隐源性和继发性机化性肺炎诊断的研究进展

Abstract
Figure/Table
References (44)
Related Citation (15)

Download: PDF (601 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract

Organizing pneumonia (OP)is a kind of lung disease with the presence of inflammatory fibrous thrombus in the distal air cavity as the main pathological manifestation.According to etiology,OP can be divided into cryptogenic organizing pneumonia(COP)and secondary organizing pneumonia(SOP).In view of the differences between COP and SOP in treatment and management,early diagnosis of them is extremely important.OP includes the process of injury,organization and reconstruction.The cause of COP is still unknown.The causes of SOP include drugs,infection,connective tissue diseases and so on.COP and SOP are not specific in clinical manifestations,and retrospective laboratory examination is of great reference value for SOP to inquire about the cause.The typical CT manifestations are multifocal consolidation,and the atypical manifestations are diverse,so it is necessary to pay attention to the differential diagnosis of other diseases.Pathohistology is the main criterion for the diagnosis of OP,including classical and special types (acute fibrinous OP and cicatricial OP),and its characteristics can correspond to the imaging mode and provide clues for the inquiry of the cause of SOP.It is very important for the diagnosis and management of COP and SOP that multidisciplinary teams synthesize clinical,laboratory,imaging and pathological information.

Key words： Organizing pneumonia Cryptogenic Secondary Interstitial lung diseases Diagnosis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2024/V31/I14/176

[1]	Cottin V，Cordier JF.Cryptogenic organizing pneumonia[J].Semin Respir Crit Care Med，2012，33（5）：462-475.
[2]	Ketchersid K.A review of organizing pneumonia[J].JAAPA，2023，36（3）：16-19.
[3]	文青，廉洁，胡婷华，等.22 例隐源性机化性肺炎的临床分析[J].临床研究，2022，30（5）：1-4.
[4]	Zhang Y，Li N，Li Q，et al.Analysis of the clinical characteristics of 176 patients with pathologically confirmed cryptogenic organizing pneumonia[J].Ann Transl Med，2020，8（12）：763.
[5]	Huang LL，Wang C，Liu Y，et al.Resolution of an insidious and migratory Mycobacterium tuberculosis-associated secondary organizing pneumonia：a case report and literature review[J].BMC Infect Dis，2023，23（1）：372.
[6]	King TE Jr，Lee JS.Cryptogenic Organizing Pneumonia[J].N Engl J Med，2022，386（11）：1058-1069.
[7]	Cortes-Santiago N，Patel KR，Wu H，et al.Pulmonary Histopathologic Findings in Pediatric Patients After Hematopoietic Stem Cell Transplantation：An Autopsy Study[J].Pediatr Dev Pathol.2023，26（4）：362-373.
[8]	Lopes JP，Ho HE，Cunningham-Rundles C.Interstitial Lung Disease in Common Variable Immunodeficiency[J].Front Immunol，2021，12：605945.
[9]	Pereira S Sr，Sousa D，Esteves AL，et al.Organizing Pneumonia and Ulcerative Colitis：A Relationship To Remember[J].Cureus，2023，15（3）：e36396.
[10]	Zeng H，Ma Y，He X，et al.Characteristics and Follow-Up of Organizing Pneumonia Associated with Haematological Malignancies[J].Int J Gen Med，2022，15：301-310.
[11]	Tzilas V，Poletti V，Bouros D.Reversed halo sign in radiation induced organizing pneumonia：natural course of the underlying pathophysiology[J].Pulmonology，2021，27（5）：460-464.
[12]	Enomoto N，Sumikawa H，Sugiura H，et al.Clinical，radiological，and pathological evaluation of "NSIP with OP overlap"pattern compared with NSIP in patients with idiopathic interstitial pneumonias[J].Respir Med，2020，174：106201.
[13]	Kligerman SJ，Kay FU，Raptis CA，et al.CT Findings and Patterns of e-Cigarette or Vaping Product Use-Associated Lung Injury：A Multicenter Cohort of 160 Cases[J].Chest，2021，160（4）：1492-1511.
[14]	Kim EJ，Kim KC.Pulmonary tuberculosis presenting secondary organizing pneumonia with organized polypoid granulation tissue：case series and review of the literature[J].BMC Pulm Med，2020，20（1）：252.
[15]	潘婷，孙铁英.抗肿瘤药物诱导的机化性肺炎的研究进展[J].中国全科医学，2022，25（14）：1772-1778.
[16]	Matsuno O.Drug-induced interstitial lung disease：mechanisms and best diagnostic approaches[J].Respir Res，2012，13（1）：39.
[17]	Zhai X，Zhang J，Tian Y，et al.The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in nonsmall cell lung cancer patients[J].Cancer Biol Med，2020，17（3）：599-611.
[18]	Palmucci S，Galioto F，Fazio G，et al.Clinical and radiological features of lung disorders related to connective-tissue diseases：a pictorial essay[J].Insights Imaging，2022，13（1）：108.
[19]	Cerro Chiang G，Parimon T.Understanding Interstitial Lung Diseases Associated with Connective Tissue Disease（CTD-ILD）：Genetics，Cellular Pathophysiology，and Biologic Drivers[J].Int J Mol Sci，2023，24（3）：2405.
[20]	Choi KJ，Yoo EH，Kim KC，et al.Comparison of clinical features and prognosis in patients with cryptogenic and secondary organizing pneumonia[J].BMC Pulm Med，2021，21（1）：336.
[21]	苏鑫，顾恒琼，李玉柱.40 例机化性肺炎临床特征[J].中华医院感染学杂志，2021，31（24）：3727-3731.
[22]	Cherian SV，Patel D，Machnicki S，et al.Algorithmic Approach to the Diagnosis of Organizing Pneumonia：A Correlation of Clinical，Radiologic，and Pathologic Features[J].Chest，2022，162（1）：156-178.
[23]	Ozdemirel TS，Bulut S，Akkurt ES，et al.Does cryptogenic organizing pneumonia change seasonal?[J].Rev Assoc Med Bras（1992），2023，69（2）：267-271.
[24]	Zhou Y，Wang L，Huang M，et al.A long-term retrospective study of patients with biopsy-proven cryptogenic organizing pneumonia[J].Chron Respir Dis，2019，16：14799731198538 29.
[25]	杨雪，孔君，孔辉，等.65 例局灶性机化性肺炎临床特征的分析[J].南京医科大学学报（自然科学版），2020，40（9）：1348-1353.
[26]	徐若男，张黎明.隐源性和感染继发机化性肺炎的临床特征及预后分析[J].临床肺科杂志，2022，27（12）：1839-1844.
[27]	王建军，吕群，余瑜曼，等.隐源性机化性肺炎与继发性机化性肺炎的诊治特点及预后比较[J].浙江医学，2019，41（9）：916-919，923.
[28]	Baha A，Y1ld1r1m F，N，et al.Cryptogenic and Secondary Organizing Pneumonia：Clinical Presentation，Radiological and Laboratory Findings，Treatment，and Prognosis in 56 Cases[J].Turk Thorac J，2018，19（4）：201-208.
[29]	Yu G，Ji H，Meng C，et al.Surgical management of organizing pneumonia：a retrospective study of 24 cases in a single Centre[J].J Cardiothorac Surg，2019，14（1）：122.
[30]	林远生，邱玉芳，袁小亮.隐源性机化性肺炎及继发性机化性肺炎的临床特征及影像特点分析[J].赣南医学院学报，2019，39（11）：1156-1159.
[31]	Y1lmaz S，Ak1nc1Y，et al.Retrospective evaluation of patients with organizing pneumonia：is cryptogenic organizing pneumonia different from secondary organizing pneumonia？[J].Tuberk Toraks，2017，65（1）：1-8.
[32]	Williams JM，Hurst P，Rajiah PS.I saw the "atoll sign"-and now I need a tropical vacation[J].Clin Imaging，2023，101：156-160.
[33]	Gbadamosi WA，Hanai B，Kim P，et al.Radiological Finding of Crazy-Paving Pattern in COVID-19 Pneumonia[J].Cureus，2022，14（6）：e26107.
[34]	Epler GR.Bronchiolitis obliterans organizing pneumonia，25 years：a variety of causes，but what are the treatment options?[J].Expert Rev Respir Med，2011，5（3）：353-361.
[35]	Ko JP，Girvin F，Moore W，et al.Approach to Peribronchovascular Disease on CT[J].Semin Ultrasound CT MR，2019，40（3）：187-199.
[36]	Marchiori E，Hochhegger B，Zanetti G.Peripheral consolidation/ground-glass opacities[J].J Bras Pneumol，2020，46（1）：e20190384.
[37]	Bradley B，Branley HM，Egan JJ，et al.Interstitial lung disease guideline：the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society[J].Thorax，2008，63（Suppl 5）：1-58.
[38]	Zare Mehrjardi M，Kahkouee S，Pourabdollah M.Radio-pathological correlation of organizing pneumonia（OP）：a pictorial review[J].Br J Radiol，2017，90（1071）：20160723.
[39]	Radzikowska E，Fijolek J.Update on cryptogenic organizing pneumonia[J].Front Med（Lausanne），2023，10：1146782.
[40]	Chen H，Kuang Y，Huang X，et al.Acute fibrinous and organizing pfneumonia：two case reports and literature review[J].Diagn Pathol，2021，16（1）：90.
[41]	Woge MJ，Ryu JH，Bartholmai BJ，et al.Cicatricial organizing pneumonia：a clinicopathologic and radiologic study on a cohort diagnosed by surgical lung biopsy at a single institution[J].Hum Pathol，2020，101：58-63.
[42]	李洪杰，王鹰，程杰，等.不典型机化性肺炎CT 影像表现及病理特征分析[J].临床放射学杂志，2022，41（12）：2201-2204.
[43]	熊焰.机化性肺炎的病理学解读[J].中国综合临床，2021，37（5）：391-394.
[44]	Fischer A，Antoniou KM，Brown KK，et al.An official European Respiratory Society/American Thoracic Society research statement：interstitial pneumonia with autoimmune features[J].Eur Respir J，2015，46（4）：976-987.